Lakefront Biotherapeutics (LKFT) Return on Capital Employed Growth (1y) (2018 - 2026)
Lakefront Biotherapeutics (LKFT) Return on Capital Employed Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 68,255.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 2,665.00 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 31,429.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 2,503.00 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 16,829.00 |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn | 1,666.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,666.00 |
| Dec 31, 2025 | 1,071.00 |
| Mar 31, 2025 | -893.00 |
| Dec 31, 2024 | -587.00 |
| Mar 31, 2024 | 558.00 |
| Mar 31, 2023 | 95.00 |
| Jun 30, 2020 | 1,293.00 |
| Mar 31, 2020 | 1,269.00 |
| Dec 31, 2019 | 1,088.00 |
| Sep 30, 2019 | 3,102.00 |
| Jun 30, 2019 | -664.00 |
| Mar 31, 2019 | 482.00 |
| Jun 30, 2018 | -187.00 |
| Mar 31, 2018 | -1,318.00 |